Naoki Mugii

517 total citations
25 papers, 341 citations indexed

About

Naoki Mugii is a scholar working on Pathology and Forensic Medicine, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Naoki Mugii has authored 25 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 13 papers in Epidemiology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Naoki Mugii's work include Systemic Sclerosis and Related Diseases (16 papers), Inflammatory Myopathies and Dermatomyositis (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Naoki Mugii is often cited by papers focused on Systemic Sclerosis and Related Diseases (16 papers), Inflammatory Myopathies and Dermatomyositis (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Naoki Mugii collaborates with scholars based in Japan, Brazil and Italy. Naoki Mugii's co-authors include Fujiko Someya, Yasuhito Hamaguchi, Minoru Hasegawa, Manabu Fujimoto, Takashi Matsushita, Kazuhiko Takehara, Shoji HORIE, K. Takehara, Shigeyuki Murono and Katsumi Inoue and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Lara D. Veeken.

In The Last Decade

Naoki Mugii

22 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Mugii Japan 9 188 169 118 103 68 25 341
Véronique Le-Guern France 7 260 1.4× 132 0.8× 141 1.2× 100 1.0× 79 1.2× 7 364
Elaine Cassidy United States 3 153 0.8× 226 1.3× 95 0.8× 125 1.2× 96 1.4× 7 355
Helle Bitter Norway 5 179 1.0× 194 1.1× 51 0.4× 73 0.7× 170 2.5× 7 350
Slavica Pavlov‐Dolijanović Serbia 9 188 1.0× 59 0.3× 100 0.8× 102 1.0× 28 0.4× 27 305
Katalin Dévényi Hungary 8 167 0.9× 180 1.1× 52 0.4× 89 0.9× 167 2.5× 14 325
Enrico De Lorenzis Italy 9 138 0.7× 69 0.4× 57 0.5× 76 0.7× 61 0.9× 40 281
Renata Miossi Brazil 12 79 0.4× 153 0.9× 54 0.5× 130 1.3× 18 0.3× 37 306
Marie Vanthuyne Belgium 10 306 1.6× 137 0.8× 94 0.8× 88 0.9× 108 1.6× 15 360
S. Josse France 6 73 0.4× 299 1.8× 50 0.4× 144 1.4× 161 2.4× 10 357
Fred Wigley United States 4 256 1.4× 80 0.5× 95 0.8× 56 0.5× 114 1.7× 5 333

Countries citing papers authored by Naoki Mugii

Since Specialization
Citations

This map shows the geographic impact of Naoki Mugii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Mugii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Mugii more than expected).

Fields of papers citing papers by Naoki Mugii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Mugii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Mugii. The network helps show where Naoki Mugii may publish in the future.

Co-authorship network of co-authors of Naoki Mugii

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Mugii. A scholar is included among the top collaborators of Naoki Mugii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Mugii. Naoki Mugii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yoshida, Akira, et al.. (2024). Different phenotypic manifestations between Brazilian and Japanese anti-MDA5 antibody-positive dermatomyositis: an international tricentric longitudinal study. Clinical and Experimental Rheumatology. 43(2). 193–201. 1 indexed citations
4.
Mugii, Naoki, et al.. (2023). Early improvement of nailfold videocapillaroscopy abnormalities in dermatomyositis patients with anti‐NXP‐2 antibody. SHILAP Revista de lepidopterología. 6(6). 245–248. 2 indexed citations
5.
Mugii, Naoki, Renata Miossi, Fernando Henrique Carlos de Souza, et al.. (2023). Patients with inflammatory myopathies overlapping with systemic sclerosis: A Brazilian-Japanese bicentric study. Archives of Rheumatology. 38(1). 138–147.
6.
Mugii, Naoki, et al.. (2022). Inflammatory myopathies overlapping with systemic sclerosis: a systematic review. Clinical Rheumatology. 41(7). 1951–1963. 8 indexed citations
8.
Hamaguchi, Yasuhito, Naoki Mugii, Takashi Matsushita, & Kazuhiko Takehara. (2020). Long‐term changes in nail fold capillary abnormalities and serum fibroblast growth factor 23 levels in dermatomyositis patients with anti‐melanoma differentiating antigen 5 antibody. The Journal of Dermatology. 48(1). 106–109. 8 indexed citations
9.
Mugii, Naoki, Fujiko Someya, Shinichi Noto, et al.. (2019). Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients. Modern Rheumatology. 30(4). 681–686. 7 indexed citations
10.
Mugii, Naoki & Fujiko Someya. (2018). Cardiopulmonary factors affecting 6-min walk distance in patients with idiopathic inflammatory myopathies. Rheumatology International. 38(8). 1443–1448. 3 indexed citations
11.
Mugii, Naoki, Takashi Matsushita, Hirokazu Okita, et al.. (2018). Long-term follow-up of finger passive range of motion in Japanese systemic sclerosis patients treated with self-administered stretching. Modern Rheumatology. 29(3). 484–490. 4 indexed citations
12.
Asano, Yoshihide, Masatoshi Jinnin, Yasushi Kawaguchi, et al.. (2018). Diagnostic criteria, severity classification and guidelines of systemic sclerosis. The Journal of Dermatology. 45(6). 633–691. 28 indexed citations
13.
Someya, Fujiko, et al.. (2017). Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis.. PubMed. 34 Suppl 100(5). 152–156. 5 indexed citations
14.
Mugii, Naoki, Minoru Hasegawa, Takashi Matsushita, et al.. (2016). Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies. PLoS ONE. 11(5). e0154746–e0154746. 73 indexed citations
15.
Someya, Fujiko, et al.. (2015). Cardiac hemodynamic response to the 6-minute walk test in young adults and the elderly. BMC Research Notes. 8(1). 355–355. 9 indexed citations
16.
Someya, Fujiko, et al.. (2013). Predictors of Exercise-Induced Oxygen Desaturation in Systemic Sclerosis Patients With Interstitial Lung Disease. Respiratory Care. 59(1). 75–80. 10 indexed citations
17.
Someya, Fujiko & Naoki Mugii. (2013). Limitations to the 6-Minute Walk Test in Dermatomyositis with Interstitial Lung Disease in comparison with Idiopathic Interstitial pneumonia. SHILAP Revista de lepidopterología. 7. CCRPM.S10764–CCRPM.S10764. 5 indexed citations
18.
19.
Mugii, Naoki, Minoru Hasegawa, Takashi Matsushita, et al.. (2011). Association between nail-fold capillary findings and disease activity in dermatomyositis. Lara D. Veeken. 50(6). 1091–1098. 56 indexed citations
20.
Mugii, Naoki, Minoru Hasegawa, Chihiro Tanaka, et al.. (2009). Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis. Lara D. Veeken. 48(6). 696–703. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026